Where are the next generation of antibiotics going to come from? Clare Sansom looks at the pipeline
The threat of antibiotic resistance is big news, but it would matter a lot less if many new ones were coming down the pipeline. Sadly, only a handful of new antibiotics have by the FDA in recent years, and no new classes. Clare Sansom looks at the efforts – from government-led initiatives to university spin-outs – to counteract the lack of progress and funding.